Sequencing of captive target transcripts identifies the network of regulated genes and functions of rimate-specific miR-522

Cell Reports

Volumn 8, Issue 4, 2014, Pages 1225-1239

  Tan, Shen Mynn ^a,b   Kirchner, Rory ^c   Jin, Jingmin ^d   Hofmann, Oliver ^c   McReynolds, Larry ^d   Hide, Winston ^c,e   Lieberman, Judy ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d NEW ENGLAND BIOLABS   (United States)

^e HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 522; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR PAX3; UNCLASSIFIED DRUG; MICRORNA 517C; MICRORNA 519A; MICRORNA 521; MESSENGER RNA; MIRN522 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANOIKIS; ARTICLE; BREAST CANCER CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME 19; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DNA CROSS LINKING; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FOXC2 GENE; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; SNAI1 GENE; SNAI2 GENE; STRUCTURAL BIOINFORMATICS; TRIPLE NEGATIVE BREAST CANCER; TWIST1 GENE; VIM GENE; ZEB2 GENE; BIOTINYLATION; CELL SEPARATION; GENE AMPLIFICATION; GENE CLUSTER; GENE CONTROL; GENE REGULATORY NETWORK; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; LUCIFERASE ASSAY; BINDING SITE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROGNOSIS; RNA INTERFERENCE; SEQUENCE ANALYSIS; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE;

PRIMATES;

BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; PROGNOSIS; RNA INTERFERENCE; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84908356160     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.07.023     Document Type: Article

References (49)

1. Aktas B., Tewes M., Fehm T., Hauch S., Kimmig R., Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 2009, 11:R46.
2. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010, 11:R106.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. *, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. EMBO Mol. Med. 2012, 4:1214-1229.
5. Bonnomet A., Syne L., Brysse A., Feyereisen E., Thompson E.W., Noël A., Foidart J.M., Birembaut P., Polette M., Gilles C. A dynamic invivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene 2012, 31:3741-3753.
6. Buffa F.M., Camps C., Winchester L., Snell C.E., Gee H.E., Sheldon H., Taylor M., Harris A.L., Ragoussis J. microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res. 2011, 71:5635-5645.
7. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. Cancer Genome Atlas Network.
8. Chi S.W., Zang J.B., Mele A., Darnell R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486.
9. DeLuca D.S., Levin J.Z., Sivachenko A., Fennell T., Nazaire M.D., Williams C., Reich M., Winckler W., Getz G. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 2012, 28:1530-1532.
10. Enerly E., Steinfeld I., Kleivi K., Leivonen S.K., Aure M.R., Russnes H.G., Rønneberg J.A., Johnsen H., Navon R., Rødland E., et al. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS ONE 2011, 6:e16915.
11. Fan J., Bertino J.R. Functional roles of E2F in cell cycle regulation. Oncogene 1997, 14:1191-1200.
12. Flicek P., Ahmed I., Amode M.R., Barrell D., Beal K., Brent S., Carvalho-Silva D., Clapham P., Coates G., Fairley S., et al. Ensembl 2013. Nucleic Acids Res. 2013, 41:D48-D55.
13. Frith M.C., Saunders N.F., Kobe B., Bailey T.L. Discovering sequence motifs with arbitrary insertions and deletions. PLoS Comput. Biol. 2008, 4:e1000071.
14. Granit R.Z., Gabai Y., Hadar T., Karamansha Y., Liberman L., Waldhorn I., Gat-Viks I., Regev A., Maly B., Darash-Yahana M., et al. EZH2 promotes a bi-lineage identity in basal-like breast cancer cells. Oncogene 2013, 32:3886-3895.
15. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., Rothballer A., Ascano M., Jungkamp A.C., Munschauer M., et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141.
16. Helwak A., Kudla G., Dudnakova T., Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013, 153:654-665.
17. Kallergi G., Papadaki M.A., Politaki E., Mavroudis D., Georgoulias V., Agelaki S. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res. 2011, 13:R59.
18. Keene J.D., Komisarow J.M., Friedersdorf M.B. RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat. Protoc. 2006, 1:302-307.
19. Kishore S., Jaskiewicz L., Burger L., Hausser J., Khorshid M., Zavolan M. A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat. Methods 2011, 8:559-564.
20. Lal A., Navarro F., Maher C.A., Maliszewski L.E., Yan N., O'Day E., Chowdhury D., Dykxhoorn D.M., Tsai P., Hofmann O., et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol. Cell 2009, 35:610-625.
21. Lal A., Thomas M.P., Altschuler G., Navarro F., O'Day E., Li X.L., Concepcion C., Han Y.C., Thiery J., Rajani D.K., et al. Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet. 2011, 7:e1002363.
22. Lamouille S., Subramanyam D., Blelloch R., Derynck R. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr. Opin. Cell Biol. 2013, 25:200-207.
23. Li M., Lee K.F., Lu Y., Clarke I., Shih D., Eberhart C., Collins V.P., Van Meter T., Picard D., Zhou L., et al. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 2009, 16:533-546.
24. Liu C., Xu P., Lamouille S., Xu J., Derynck R. TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. Mol. Cell 2009, 35:26-36.
25. Loeb G.B., Khan A.A., Canner D., Hiatt J.B., Shendure J., Darnell R.B., Leslie C.S., Rudensky A.Y. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol. Cell 2012, 48:760-770.
26. Lowery A.J., Miller N., Devaney A., McNeill R.E., Davoren P.A., Lemetre C., Benes V., Schmidt S., Blake J., Ball G., Kerin M.J. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res. 2009, 11:R27.
27. Lv Q., Wang W., Xue J., Hua F., Mu R., Lin H., Yan J., Lv X., Chen X., Hu Z.W. DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer. Cancer Res. 2012, 72:3238-3250.
28. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T.T., Valastyan S., et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 2010, 12:247-256.
29. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 2011, 17:3.
30. Matys V., Kel-Margoulis O.V., Fricke E., Liebich I., Land S., Barre-Dirrie A., Reuter I., Chekmenev D., Krull M., Hornischer K., et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 2006, 34:D108-D110.
31. Milewski R.C., Chi N.C., Li J., Brown C., Lu M.M., Epstein J.A. Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development 2004, 131:829-837.
32. Ørom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 2008, 30:460-471.
33. Rippe V., Dittberner L., Lorenz V.N., Drieschner N., Nimzyk R., Sendt W., Junker K., Belge G., Bullerdiek J. The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS ONE 2010, 5:e9485.
34. Sieuwerts A.M., Mostert B., Bolt-de Vries J., Peeters D., de Jongh F.E., Stouthard J.M., Dirix L.Y., van Dam P.A., Van Galen A., de Weerd V., et al. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin. Cancer Res. 2011, 17:3600-3618.
35. Song Y., Washington M.K., Crawford H.C. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res. 2010, 70:2115-2125.
36. Song S.J., Poliseno L., Song M.S., Ala U., Webster K., Ng C., Beringer G., Brikbak N.J., Yuan X., Cantley L.C., et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 2013, 154:311-324.
37. Su H., Trombly M.I., Chen J., Wang X. Essential and overlapping functions for mammalian Argonautes in microRNA silencing. Genes Dev. 2009, 23:304-317.
38. Tan S.M., Altschuler G., Zhao T.Y., Ang H.S., Yang H., Lim B., Vardy L., Hide W., Thomson A.M., Lareu R.R. Divergent LIN28-mRNA associations result in translational suppression upon the initiation of differentiation. Nucleic Acids Res. 2014, 42:7997-8007.
39. Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455:1124-1128.
40. Thomas M., Lieberman J., Lal A. Desperately seeking microRNA targets. Nat. Struct. Mol. Biol. 2010, 17:1169-1174.
41. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
42. Venkov C., Plieth D., Ni T., Karmaker A., Bian A., George A.L., Neilson E.G. Transcriptional networks in epithelial-mesenchymal transition. PLoS One 2011, 6:e25354.
43. Vetter G., Saumet A., Moes M., Vallar L., Le Béchec A., Laurini C., Sabbah M., Arar K., Theillet C., Lecellier C.H., Friederich E. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene 2010, 29:4436-4448.
44. Wang L., Wang S., Li W. RSeQC: quality control of RNA-seq experiments. Bioinformatics 2012, 28:2184-2185.
45. Wiggan O., Fadel M.P., Hamel P.A. Pax3 induces cell aggregation and regulates phenotypic mesenchymal-epithelial interconversion. J.Cell Sci. 2002, 115:517-529.
46. Wu S., Huang S., Ding J., Zhao Y., Liang L., Liu T., Zhan R., He X. Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene 2010, 29:2302-2308.
47. Xia Z., Clark P., Huynh T., Loher P., Zhao Y., Chen H.W., Ren P., Rigoutsos I., Zhou R. Molecular dynamics simulations of Ago silencing complexes reveal a large repertoire of admissible 'seed-less' targets. Sci. Rep. 2012, 2:569.
48. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008, 14:818-829.
49. Zisoulis D.G., Lovci M.T., Wilbert M.L., Hutt K.R., Liang T.Y., Pasquinelli A.E., Yeo G.W. Comprehensive discovery of endogenous Argonaute binding sites in Caenorhabditis elegans. Nat. Struct. Mol. Biol. 2010, 17:173-179.